Home » BioVex Tops Off $70 Million Venture Round
BioVex Tops Off $70 Million Venture Round
BioVex Inc., a developer of potential cancer-fighting technologies, has added $30 million in
venture capital.
Boston Business Journal
Boston Business Journal
Upcoming Events
-
07May
-
14May
-
30May